Panobacumab - CAS 885053-97-4

Panobacumab (KBPA101) is a fully humanised monoclonal antibody targeting Pseudomonas aeruginosa, specifically targeting the O-polysaccharide (OPS) component of the bacterial outer membrane LPS. It is effective against certain drug-resistant strains of P. aeruginosa, reduces pulmonary inflammation, and enhances the clearance of bacteria from the lungs by neutrophils.

Antibacterial

Microbiology/Virology

884952

0.988

-20°C

Ice Packs

Inhibitory Antibodies